Fusion of two distinct peptide exosite inhibitors of Factor VIIa. [PDF]
Biochem J, 2002 Roberge M +4 more
europepmc +1 more source
Recent insights on biochemical and molecular basis for developing antihaemostatic agents: A review. [PDF]
Indian J Clin Biochem, 2004 Kumar R +4 more
europepmc +1 more source
Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase. [PDF]
Biochem J, 1990 Krause J +3 more
europepmc +1 more source
Development of the nitrone-based spin trap agent NXY-059 to treat acute ischemic stroke. [PDF]
CNS Drug Rev, 2003 Lapchak PA, Araujo DM.
europepmc +1 more source
Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA). [PDF]
Clin Cardiol, 2001 Gibson CM, Marble SJ.
europepmc +1 more source
The effect of treatment of the rat with bacterial endotoxin on gluconeogenesis and pyruvate metabolism in subsequently isolated hepatocytes. [PDF]
Biochem J, 1993 Jones CG, Titheradge MA.
europepmc +1 more source
New plasminogen activators: a clinical review. [PDF]
Clin Cardiol, 1999 Ross AM.
europepmc +1 more source
Inhibition of hepatic gluconeogenesis by nitric oxide: a comparison with endotoxic shock. [PDF]
Biochem J, 1994 Horton RA +3 more
europepmc +1 more source
Evidence for the participation of aspartate aminotransferase in hepatic glucose synthesis in the suckling newborn rat. [PDF]
Biochem J, 1978 Ferré P, Williamson DH.
europepmc +1 more source
Characterization of the binding of plasminogen activators to plasma membranes from human liver. [PDF]
Biochem J, 1992 Nguyen G +3 more
europepmc +1 more source